Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HMGN1P31 (high mobility group nucleosome binding domain 1 pseudogene 31) is classified as a human pseudogene and does not encode a functional protein. Pseudogenes such as HMGN1P31 share sequence similarity with protein-coding genes but lack the ability to produce a functional product due to disabling mutations or absence of regulatory elements[1][3][4]. There is no evidence suggesting HMGN1P31 has a regulatory or pathological role, nor is it considered a drug target. HMGN1P31 is a pseudogene, not a therapeutic target, and does not have biomedical relevance as a receptor, enzyme, transporter, or regulatory molecule in current scientific knowledge[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group nucleosome binding domain 1 pseudogene 31 (HMGN1P31).